Concepedia

M O Behm

MO

3

Publications

83

Citations

3

H-Index

2012

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

M O Behm is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in atherosclerosis, pharmacokinetic modeling, and cardiovascular disease.

Top concepts

Publications per year

2012–2014

3

Publications

3

A Randomized, Placebo-Controlled Study of the Effects of Telcagepant on Exercise Time in Patients With Stable Angina

Bernard Chaitman, Andrew P. Ho, M O Behm et al. · Clinical Pharmacology & Therapeutics · 2012 · 58 citations

Lack of hemodynamic interaction between CGRP-receptor antagonist telcagepant (MK-0974) and sumatriptan: Results from a randomized study in patients with migraine

Marleen Depré, Caitlin S. MacLeod, John Palcza et al. · Cephalalgia · 2013 · 13 citations · Full text

Prediction of Clinical Irrelevance of PK Differences in Atorvastatin Using PK/PD Models Derived From Literature-Based Meta-Analyses

Ryan Vargo, A Adewale, M O Behm et al. · Clinical Pharmacology & Therapeutics · 2014 · 12 citations · Full text

, , +22

Rows per page

1–3 of 3